Innovation &
Pipeline
Finding solutions that improve patients’ lives
We aim to deliver major therapeutic advances by treating patients with a high burden of disease, offering clear benefits for patients and sound health economics for society. Our exciting R&D pipeline includes several new drug candidates and technologies to improve patients’ lives.
At Grünenthal, there is close collaboration between all stakeholders involved in research, and each is equally important. Our networked approach to R&D means that we can interlink and supplement our own expertise with external knowledge, leading to improved outcomes.
Latest Updates
Omics Approach to Identify Pain Pathways
Read our article about the steps we have taken to generate an integrated disease pathway map for pain which contains the major pathophysiological components.
Discover morePsychosocial Factors in Profiling IBS Patients
Read our article on how relevant the neuro-visceral axis is for the expression of symptoms from which visceral pain conditions, like IBS, can originate.
Discover morePatient Focus Groups as a Strategy to Engage with Patients
Read our article which introduces patient focus group methodology, its role in pain research, and provides advice on planning and running a patient focus group.
Discover morePatient Focus Groups as a Strategy to Engage with Patients
Read our article which introduces patient focus group methodology, its role in pain research, and provides advice on planning and running a patient focus group.
Discover more